Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.08), $0.05 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.3 million versus the consensus estimate of $1.45 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.